Nebulizers Market Research Report - Forecast till 2027

Nebulizers Market: By Type (Mesh, Jet, Ultrasonic), Usage (Reusable, Disposable), Portability (Tabletop, Portable), End User (Hospitals and Clinics, Homecare, Others) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast to 2027

ID: MRFR/HC/8108-HCR | February 2021 | Region: Global | 90 pages

Nebulizers Market Forecast


Nebulizers Market is expected to hold a value of USD 1,629.7 Million by 2027 and is expected to register a growth of 7.32% from 2020 to 2027.


Nebulizers Market Synopsis


Nebulizers are a device that has the capability of changing a medication from a liquid to a mist so that it can be inhaled into the lungs. High demand for respiratory devices, including nebulizers, due to the outbreak of COVID-19 globally, growing need for rescue medication, increasing prevalence of respiratory diseases, and rising demand for home healthcare devices are the key factors that are expected to drive the nebulizers market growth. Moreover, the growing geriatric population, increasing consumption of alcohol, tobacco, cigarettes, and other such products may lead to respiratory diseases, and the rising number of initiatives taken by the government as well as the private organizations are also expected to boost the nebulizers market growth.


Nebulizers Market Influencer


The outbreak of COVID-19, leading to increased demand for respiratory devices, including nebulizers.


Nebulizers Market Drivers



  • High demand for respiratory devices, including nebulizers, due to outbreak of COVID-19 globally



  • Growing need for rescue medication. Uncertain asthma attacks are the major reasons to increase the demand for nebulizers. According to the American College of Allergy, Asthma, and Immunology, every year more than 3,500 people die because of asthma. Rescue medication, such as the nebulizers, helps in better serving the patients suffering from asthma every year, hence driving the nebulizers market growth.



  • Increasing prevalence of chronic respiratory diseases. According to a report published by the World Health Organization (WHO), in 2017, approximately 65 million people suffered from chronic obstructive pulmonary disease (COPD) and 3 million die because of it every year, globally.



  • Rising demand for home healthcare devices



  • Growing geriatric population



  • Increasing consumption of alcohol, tobacco, cigarettes, and other such products that may lead to respiratory diseases


Nebulizers Market Restraints



  • Loss of drug during the nebulization process

  • Availability of substitutes of nebulizers

  • Side effects of nebulizer solutions


Nebulizers Market Segmentation


By Type



  • Mesh: This segment is expected to grow owing to the growing patient acceptance for mesh nebulizers and its accurate drug delivery. It is further segmented into active mesh nebulizers and passive mesh nebulizers.



  • Jet: This segment is expected to account for the largest market share owing to its compact size and minimal drug wastage.



  • Ultrasonic: Rising popularity of ultrasonic nebulizers owing to the reduced size of drug droplets is anticipated to drive the nebulizers market growth.


By Usage



  • Reusable: The market for reusable nebulizers is expected to grow owing to its feature of using for months as compared to disposable nebulizers which can be used 10 times.



  • Disposable: Increasing popularity of disposable nebulizers due to its high usage for many years is anticipated to drive the nebulizers market growth.


By Portability



  • Tabletop: Less cost as compared to portable nebulizers is expected to drive the nebulizers market growth.

  • Portable: Rising adoption of portable nebulizers by patients is anticipated to drive the nebulizers market growth.


By End-User



  • Hospitals and Clinics: This segment is expected to grow significantly, owing to the rising patient population.

  • Homecare: This segment is expected to demonstrate the fastest growth owing to its cost-effectiveness over other options.

  • Others: This includes research and academic institutes and specialty centers, among others.


By Region



  • Americas: The largest regional market. The rising prevalence of respiratory disorders and favorable reimbursement schemes in the region is expected to drive the nebulizers market growth. According to data published by the Centers for Disease Control and Prevention in May 2017, about 9 million people in the US were diagnosed with chronic bronchitis. Moreover, increasing awareness regarding nebulizers amongst the people is also expected to contribute to market growth.



  • Europe: The nebulizers market in Europe held the second-largest position in 2018 owing to the growing geriatric population. According to a report published by the European Union, approximately 29.6% of people in Europe are above the age of 65. Moreover, rising demand for technologically advanced devices in the region is also expected to boost the nebulizers market growth.



  • Asia-Pacific: The fastest-growing regional market. The growth of the nebulizers market in this region is owing to the rising number of respiratory disorder cases. According to a report published by the World Health Organization (WHO), in 2018, approximately 1.31 billion people in India suffered from asthma. The increasing focus of market players on the Asia-Pacific market is also expected to boost nebulizers market growth.



  • Middle East & Africa: The market is expected to show steady growth due to the rising burden of respiratory diseases. According to a report published by the National Center for Biotechnology Information (NCBI) in May 2018, the prevalence of asthma in the Middle Eastern countries ranges from 4.4% to 7.6%. Furthermore, slowly developing healthcare infrastructure is also expected to boost the nebulizers market growth.


Nebulizers Market Key Players



  • OMRON Healthcare (Japan)

  • Koninklijke Philips N.V. (Netherlands)

  • PARI (US)

  • Vectura Group plc (UK)

  • Rossmax International Ltd (Taiwan)

  • Briggs Healthcare (US)

  • GF Health Products, Inc. (US)

  • Beurer GmBH (Germany)

  • Agilent Technologies, Inc. (US)

  • Drive DeVilbiss Healthcare (US)

  • Invacare Corporation (US)

  • Braun Melsungen AG (Germany)



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: USD 1,629.7 Million
  CAGR   7.32% (2020-2027)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Usage, Portability and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   OMRON Healthcare (Japan), Koninklijke Philips N.V. (Netherlands), PARI (US), Vectura Group plc (UK), Rossmax International Ltd (Taiwan), Briggs Healthcare (US), GF Health Products, Inc. (US), Beurer GmBH (Germany), Agilent Technologies, Inc. (US), Drive DeVilbiss Healthcare (US), Invacare Corporation (US), and B. Braun Melsungen AG (Germany).
  Key Market Opportunities   The Outbreak of COVID-19, Leading to Increased Demand for Respiratory Devices, including nebulizers.
  Key Market Drivers

  • Rising Demand for Home Healthcare Devices.
  • Growing Need for Rescue Medication.
  • Growing Geriatric Population


  • Frequently Asked Questions (FAQ) :


    Nebulizer market is projected to hold a market value of USD 1,629.7 million by 2027.

    Nebulizer market is anticipated to expand at a CAGR of 7.32% by the end of 2027.

    The spread of COVID-19 has resulted in a surged demand for respiratory devices, including nebulizers, which is anticipated to be the most significant factor driving the global nebulizer market.

    Loss of drug during the nebulization process, side effects of nebulizer solutions, and availability of substitutes of nebulizers are likely to hinder the global nebulizer market.

    OMRON Healthcare (Japan), Rossmax International Ltd (Taiwan), Koninklijke Philips N.V. (Netherlands), Vectura Group plc (UK) are some of the established players of the global nebulizer market.



    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.